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Abstract
Background: It is generally accepted that the risk of cerebral palsy decreases with increasing
gestational age of live born infants. However, recent studies have shown that cerebral palsy often
has prenatal antecedents including congenital malformations, vascular insults and maternal
infection. Cerebral palsy is therefore better viewed as occurring among fetuses, rather than among
infants. We explored the epidemiologic implications of this change in perspective.
Methods: We used recently published data from Shiga Prefecture, Japan and from North-East
England to examine the pattern of gestational age-specific rates of cerebral palsy under these
alternative perspectives. We first calculated gestational age-specific rates of cerebral palsy as per
convention, by dividing the number of cases of cerebral palsy identified among live births within any
gestational age category by the number of live births in that gestational age category. Under the
alternative formulation, we calculated gestational age-specific rates of cerebral palsy by dividing the
number of cases of cerebral palsy identified among live births within any gestational age category
by the number of fetuses who were at risk of being born at that gestation and being afflicted with
cerebral palsy.
Results:  Under the conventional formulation, cerebral palsy rates decreased with increasing
gestational age from 63.9 per 1,000 live births at <28 weeks gestation to 0.9 per 1,000 live births
at 37 or more weeks gestation. When fetuses were viewed as potential candidates for cerebral
palsy, cerebral palsy rates increased with increasing gestational age from 0.08 per 1,000 fetuses at
risk at <28 weeks gestation to 0.9 per 1,000 fetuses at risk at 37 or more weeks gestation.
Conclusions:  The fetuses-at-risk approach is the appropriate epidemiologic formulation for
calculating the gestational age-specific rate of cerebral palsy from a causal perspective. It shows that
the risk of cerebral palsy increases as gestational duration increases. This compelling view of
cerebral palsy risk may help refocus research aimed at understanding and preventing cerebral palsy.
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Background
Cerebral palsy refers to a heterogeneous group of central
nervous system disorders that manifest aberrant control of
movement or posture, are present since early in life, and
are not the result of recognized progressive disease [1,2].
The prevalence of cerebral palsy is approximately 1.0 to
2.3 per 1,000 live births [1]. There is a strong inverse rela-
tionship between gestational age at birth and cerebral
palsy [1] with rates being several-fold higher among very
preterm live births as compared with term live births.
Although complications of labour and delivery were pre-
viously viewed as the main causal factors, more recent evi-
dence has implicated prenatal factors in the pathogenesis
of cerebral palsy [1-5]. The latter include congenital mal-
formations, vascular insults (e.g., those causing prenatal
stroke) and maternal infection [1-3]. This emphasis on
intrauterine factors led us to question the conventional
epidemiologic formulation expressing the gestational age
relationship of cerebral palsy. A predominantly prenatal
etiology implies that fetuses, rather than live births, are
the appropriate candidates at risk for developing cerebral
palsy. We explored the epidemiologic implications of this
change in perspective by contrasting the patterns of gesta-
tional age-specific cerebral palsy rates under the conven-
tional and alternative formulations.
Methods
We used recently published data from two population-
based epidemiologic studies [6,7] to examine the conven-
tional and alternative propositions regarding the relation-
ship of gestational age with cerebral palsy. The first study
from Shiga Prefecture, Japan [6] documented cerebral
palsy rates among 6 year-old children between 1977 and
1991. The second study from North-East England [7] pro-
vided cerebral palsy rates between 1970 and 1994, with
cerebral palsy assessment carried out between 4 and 10
years of age [8].
We first calculated gestational age-specific rates of cerebral
palsy as per convention, by dividing the number of cases
of cerebral palsy identified among live births within any
gestational age category (e.g., 28–31 weeks) by the
number of live births in that gestational age category (e.g.,
28–31 weeks). Under the alternative formulation, we cal-
culated gestational age-specific rates of cerebral palsy by
dividing the number of cases of cerebral palsy identified
among live births within any gestational age category by
the number of fetuses who were at risk of being born at
that gestation and being afflicted with cerebral palsy. For
instance, all fetuses who delivered between 28–31 weeks
as well as fetuses who delivered at gestational ages greater
than 31 weeks were included in the denominator for cal-
culating the gestational age-specific rate of cerebral palsy
at 28–31 weeks. This implies that a fetus who went on to
deliver at term was at risk of being born at 28 weeks gesta-
tion and being afflicted with cerebral palsy. Figure 1 pro-
vides a schematic depiction of the proposed survival
analysis model, with cerebral palsy assigned to the point
of birth and survival time censored at birth.
The two formulations of gestational age-specific cerebral
palsy rates were graphed and the fetuses-at-risk approach
was also used to examine temporal trends in gestational
age-specific rates of cerebral palsy in Shiga Prefecture,
Japan and in North-East England.
Results
Gestational age-specific rates of cerebral palsy declined
sharply with increasing gestation under the conventional
calculation (Figure 2). On the other hand, rates of cerebral
palsy increased dramatically with increasing gestational
age when the fetuses-at-risk approach was used (Figure 2).
Table 1 shows the numbers of live births, cases of cerebral
palsy, fetuses at risk and the two alternative gestational
age-specific rates of cerebral palsy in Shiga Prefecture,
Japan.
Under the conventional formulation, the rate of cerebral
palsy was extremely high among live births that occurred
at early gestation (63.9 per 1,000 live births at <28 weeks
gestation) and low at later gestational ages when most
births occurred (0.9 per 1,000 live births at ≥37 weeks).
Under the alternative fetuses-at-risk formulation, the rate
of cerebral palsy was extremely low at early gestation
because of the large number of fetuses potentially at risk
for cerebral palsy (0.08 per 1,000 fetuses at risk) and sev-
eral-fold higher at later gestation ages. The rate at ≥37
weeks gestation (0.9 per 1,000 fetuses at risk) was identi-
cal under both formulations (by definition). The increase
in the risk of cerebral palsy with increasing gestation
under the fetuses-at-risk formulation was a consequence
of both a modest decline in the number of fetuses at risk
(from 225,786 at 28 weeks to 217,675 at 37 weeks) and a
relatively large increase in the number of cerebral palsy
cases at later gestational ages (from 55 cases at 28–31
weeks to 201 cases at ≥37 weeks, Table 1).
Temporal trends in both the Shiga Prefecture and North-
East England showed increases in rates of cerebral palsy at
preterm gestation (Figure 3). In North-East England, rates
of cerebral palsy appeared to decrease at post-term gesta-
tion, although this difference was not statistically signifi-
cant (p = 0.95).
Discussion
The fetuses-at-risk approach for defining cerebral palsy
risk shows that cerebral palsy rates increase with increas-
ing gestational age. This represents a compelling view of
cerebral palsy risk since it is based on an appropriateBMC Pregnancy and Childbirth 2003, 3 http://www.biomedcentral.com/1471-2393/3/8
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Schematic depiction of a survival analysis model for cerebral palsy risk Figure 1
Schematic depiction of a survival analysis model for cerebral palsy risk. Schematic depiction of a survival analysis model for cer-
ebral palsy risk with post-menstrual age on the X-axis. Two arbitrary periods of risk are shown. In the first risk period, there is 
one case of cerebral palsy, 3 live births and 15 fetuses at risk, while in the second risk period there is one case of cerebral 
palsy, 6 live births and 8 fetuses at risk. Under the conventional formulation of gestational age-specific cerebral palsy, this 
implies a cerebral palsy rate of 1/3 in the first risk period and 1/6 in the second risk period. Under the fetuses-at-risk formula-
tion, the rates of cerebral palsy are 1/15 and 1/8 in the first and second risk periods, respectively.
Schematic depiction of a survival analysis model for cerebral 
palsy (CP) risk
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Gestational age-specific cerebral palsy rates based on alternative formulations (live births vs fetuses-at-risk) Figure 2
Gestational age-specific cerebral palsy rates based on alternative formulations (live births vs fetuses-at-risk). Gestational age-
specific rates of cerebral palsy based on live births within a gestational age category (primary Y-axis) and based on the number 
of fetuses at risk for cerebral palsy (secondary Y-axis), Shiga Prefecture, Japan [6] (top) and North-East England [7] (bottom).
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identification of the candidates at risk for cerebral palsy.
The secular increase in the rate of cerebral palsy at preterm
gestation (Figure 2) is well understood and is believed to
be a consequence of increases in survival among preterm
live births due to improvements in neonatal care [1].
The fetuses-at-risk approach was previously proposed for
calculating the gestational age-specific risk of stillbirth [9-
11]. More recently, it has been used to explain the paradox
of intersecting perinatal mortality curves and other para-
doxical phenomena [12-14]. When the fetuses-at-risk
approach is used to calculate stillbirth or perinatal death
rates, it is observed that gestational age-specific stillbirth
[9-11] and perinatal mortality rates [12-14] increase with
increasing gestational age. The fetuses at risk approach
also shows that cerebral palsy rates increase similarly with
increasing gestational duration. Recent recognition of the
role of prenatal factors in the etiology of cerebral palsy
supports this perspective. The patterns of gestational age-
specific stillbirth [9-11], neonatal death [12-14] and cere-
bral palsy observed under the fetuses-at risk formulation
are congruent and the formulation is appropriate because
a fetus at any gestation is at risk of birth, death and cere-
bral palsy at that gestation [13].
Fetuses in adverse uterine environments are at an
increased risk of both cerebral palsy and birth. The
increase in cerebral palsy risk with increasing gestational
age suggests that in a small fraction of pregnancies the
uterine environment becomes increasingly compromised
as the duration of pregnancy increases. This perspective is
also consistent with the high rates of cerebral palsy
observed among live births at very early gestation. Very
preterm birth is typically the result of a adverse uterine
environment, which is in fact also closely associated with
the development of cerebral palsy. The traditional formu-
lation of gestational age-specific cerebral palsy risk (per
1,000 live births at any gestational age) represents a non-
causal, prognostic model [15] which is well suited for pre-
diction purposes (with prognosis set at birth).
Our alternative formulation of the gestational age-specific
pattern of cerebral palsy is important because it represents
a causal model which provides insight into a biological
process. For instance, under this perspective, the higher
rates of preterm birth and the higher rates of cerebral palsy
among multiple births are better viewed as the terminal
events of an adverse intrauterine process. This is in contra-
distinction to the conventional view [1] that "the increase
in risk [of cerebral palsy] associated with multiple gesta-
tions is chiefly related to the higher rate of premature
delivery in such pregnancies...." [[16], p.1767]. Further,
our finding that rates of cerebral palsy increase with
increasing gestational age is consistent with and sup-
ported by concurrent increases in the rates of several other
related perinatal phenomena. For instance, incidence
rates of maternal complications such as chorioamnionitis,
a known risk factor for cerebral palsy [17,18], increase as
gestational age advances [19]. Similarly, the rate of intra-
uterine growth restriction, another risk factor for cerebral
palsy [18,20], also increases with increasing gestational
duration [12-14].
Accepting that gestational age-specific rates of cerebral
palsy increase with increasing gestation will help to refo-
cus research aimed at better understanding and prevent-
ing cerebral palsy. For instance, it would be important to
determine if the recent increases in medically-indicated
labour induction and/or cesarean delivery at term and
post-term gestation [21-23] have resulted in declines in
cerebral palsy among fetuses reaching at least 37 weeks
gestation. Similarly, recent changes [24-26] in the gesta-
tional age distribution of twin and triplet births (eg., pre-
term birth rates among twins in the United States have
increased from 41% in 1981 to 55% in 1997 due to
increases in labour induction and/or cesarean delivery
[26]) may have resulted in declines in cerebral palsy rates.
Table 1: Gestational age-specific rates of cerebral palsy based on live births within a gestational age category and based on the number 
of fetuses at risk for cerebral palsy, Shiga Prefecture, Japan [6], 1977 to 1991.
Gestational age 
(weeks)
Live births Cases of cerebral 
palsy
Rate of cerebral 
palsy†
Fetuses at risk for 
cerebral palsy
Rate of cerebral 
palsy‡
<28 266 17 63.9 226,052 0.08
28–31 780 55 70.5 225,786 0.24
32–36 7,331 52 7.1 225,006 0.23
≥37 217,675 201 0.9 217,675 0.92
Total¶ 226,052 325 1.4 226,052 1.44
† rate per 1,000 live births, calculated using the number of live births within the gestational age category as the denominator. ‡ rate per 1,000 
fetuses at risk, calculated using the number of fetuses at risk for cerebral palsy at the particular gestational age as the denominator. ¶ excluding live 
births with missing/unknown gestational age.BMC Pregnancy and Childbirth 2003, 3 http://www.biomedcentral.com/1471-2393/3/8
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Temporal trends in gestational age-specific rates of cerebral palsy based on the fetuses-at-risk approach Figure 3
Temporal trends in gestational age-specific rates of cerebral palsy based on the fetuses-at-risk approach. Temporal trends in 
gestational age-specific rates of cerebral palsy based on the fetuses-at-risk approach, Shiga Prefecture, Japan, 1977–81 versus 
1987–91 [6] (top) and North-East England, 1970–74 versus 1990–94 [7] (bottom).
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Under the fetuses-at-risk formulation, a decline in cere-
bral palsy rates would be the expected consequence of the
recent increases in labour induction and/or cesarean
delivery, if the obstetric intervention preceded not only
the onset of spontaneous labour but also the point at
which critical neurologic injury occurred. Note that under
the traditional formulation of gestational age-specific cer-
ebral palsy rates [1,16], increases in cerebral palsy would
be the expected consequence of the iatrogenic increase in
preterm birth rates among twins and triplets [24-26].
However, such research into the effect of recent increases
in obstetric intervention needs to account for potential
increases in cerebral palsy rates which may have occurred
secondary to secular improvements in survival i.e., the
focus cannot be on cerebral palsy alone but on death
(including stillbirth and infant death) and cerebral palsy.
Other challenges include the need for addressing tempo-
ral changes in methods of gestational age ascertainment
(menstrual-based versus ultrasound-based).
The categorization of gestational age into intervals of une-
qual duration (based on the categories in the published
literature [6,7]) represents a minor limitation of our char-
acterization of gestational age-specific rates of cerebral
palsy. This limitation (8 week period of risk between 20–
27 weeks, 4 weeks between 28–31 weeks, 5 weeks
between 32–36 weeks and 6+ weeks between 37 and 42+
weeks gestation) does not compromise the general pattern
of gestation age-specific cerebral palsy risk, however. Sim-
ilarly, a small approximation is involved in our estimates
of the number of fetuses at risk since the original
publications [6,7] did not provide gestational age-specific
counts of stillbirths. The calculation of the number of
fetuses-at-risk for the data from North-East England also
excluded neonatal deaths since the original publication
provided information on neonatal survivors only [7].
Nevertheless, the pattern of gestational age-specific cere-
bral palsy from Shiga Prefecture and from North-East Eng-
land are similar (Figures 2 and 3). This is because the
losses (deaths) are small relative to the size of the denom-
inator (fetuses-at-risk).
A potential limitation inherent in our survival analysis
model (Figure 1) arises because cerebral palsy is assigned
to the point of birth. Whereas this representation is ideal
for cerebral palsy due to complications of labour and
delivery and cerebral palsy occurring in the period imme-
diately preceding birth, the method will systematically
overestimate the gestational age at which neurologic
injury occurs if cerebral palsy occurrence substantially pre-
cedes birth. The gestational age-specific pattern of cerebral
palsy risk will not be seriously affected by this bias, how-
ever, given its systematic nature. Furthermore, it is proba-
ble that in many cases the adverse intrauterine
environment which causes the critical neurologic injury
also leads to labour i.e., critical neurologic injury and
birth occur in close temporal proximity. Cases of cerebral
palsy where the cause occurs after birth are not a serious
concern given the relative rarity of such events and
because such cases can be identified and excluded (as
done in North-East England [7]).
Conclusions
Recent evidence, which suggests that cerebral palsy has a
predominantly prenatal etiology, implies that fetuses at
any gestation (rather than live births at that gestation)
constitute the epidemiologically appropriate denomina-
tor for calculating gestational age-specific cerebral palsy
rates. This leads to an alternative formulation of gesta-
tional age-specific cerebral palsy rates (i.e., the fetuses-at-
risk approach), which shows that cerebral palsy rates
increase as gestational age increases. The biological and
epidemiologic perspective that emerges from this refor-
mulation may help refocus research efforts aimed at better
understanding and preventing cerebral palsy. The tradi-
tional formulation of gestational age-specific cerebral
palsy rates is better viewed as a non-causal model which is
appropriate for prediction/prognostic purposes.
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